Clearmind Medicine Inc. Stock Canadian Securities Exchange
Equities
CMND
CA1850534027
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 2.46M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.39M | Net income 2023 | -8M -11.01M | EV / Sales 2022 | - |
Net cash position 2022 | 388K 534K | Net cash position 2023 | 5.51M 7.59M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |